CIK: 0001381843
申报总市值
US$3.1亿
申报季度: 2026-03-31 · 持股只数: 39
Atle Fund Management AB在最新一期 13F 报告中披露了 39 项持股，申报期为 2026-03-31，总持股市值约为 US$3.1亿，季度换手率为 32.2%。
Atle Fund Management AB 目前披露的持仓，Herfindahl 集中度指数为 0.036——换算下来相当于约 28 个等权重仓位，与其实际披露的 39 只持仓相当接近。资金分布相对平均，并未集中于少数标的。
整体仓位大小相当一致（变异系数为 0.65），显示该机构在资金配置上采取较有纪律、规则化的方式。
最新申报季度中，并未观察到明显偏向加仓既有大仓位或大举建立新仓位的倾向。
减仓 ABBV
0.0% -US$1433.2万
减仓 LLY
+27.6% -US$661.3万
减仓 NBIX
-5.4% -US$559.0万
减仓 ISRG
+217.4% -US$319.8万
减仓 TMO
-23.2% -US$288.4万
加仓 MRK
-82.7% US$231.1万
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | 股票-医疗保健 | 8.67% | -2.00% | +27.59% | |
| 2 | MRK | Merck & Co. INC. | 股票-医疗保健 | 7.40% | +0.83% | -82.71% | |
| 3 | TMO | Thermo Fisher Scientific INC | 股票-医疗保健 | 4.67% | -0.86% | -23.16% | |
| 4 | ONC | Beone Medicines Ltd-adr | 股票-其他 | 3.92% | — | +3.18% | |
| 5 | JNJ | Johnson & Johnson | 股票-医疗保健 | 3.86% | +3.86% | NEW | |
| 6 | BBIO | Bridgebio Pharma INC | 股票-医疗保健 | 3.84% | +0.39% | -21.18% | |
| 7 | VRTX | Vertex Pharmaceuticals INC | 股票-医疗保健 | 3.61% | +0.29% | — | |
| 8 | ABBV | Abbvie INC | 股票-医疗保健 | 3.35% | -4.54% | — | |
| 9 | SYK | Stryker CORP | 股票-医疗保健 | 3.09% | +0.08% | — | |
| 10 | ISRG | Intuitive Surgical INC | 股票-医疗保健 | 3.05% | -0.98% | +217.40% | |
| 11 | IONS | Ionis Pharmaceuticals INC | 股票-医疗保健 | 3.03% | +0.70% | -69.83% | |
| 12 | MIRM | Mirum Pharmaceuticals INC | 股票-其他 | 3.03% | +0.77% | +118.28% | |
| 13 | CVS | Cvs Health CORP | 股票-医疗保健 | 2.99% | +0.29% | -77.68% | |
| 14 | RVMD | Revolution Medicines INC | 股票-医疗保健 | 2.93% | +0.64% | +584.43% | |
| 15 | BSX | Boston Scientific CORP | 股票-医疗保健 | 2.86% | -0.45% | -62.80% | |
| 16 | AMGN | Amgen INC | 股票-医疗保健 | 2.81% | +0.52% | — | |
| 17 | EW | Edwards Lifesciences CORP | 股票-医疗保健 | 2.67% | +2.67% | NEW | |
| 18 | ALKS | Alkermes plc | 股票-医疗保健 | 2.66% | +0.50% | — | |
| 19 | INCY | Incyte CORP | 股票-医疗保健 | 2.57% | +0.34% | -28.31% | |
| 20 | NBIX | Neurocrine Biosciences INC | 股票-医疗保健 | 2.54% | -1.75% | -5.39% | |
| 21 | GILD | Gilead Sciences INC | 股票-医疗保健 | 2.31% | +0.32% | -5.57% | |
| 22 | KRYS | Krystal Biotech INC | 股票-医疗保健 | 2.19% | -0.47% | +11.01% | |
| 23 | COR | Cencora INC | 股票-医疗保健 | 2.13% | -0.43% | -1.27% | |
| 24 | IRTC | Irhythm Holdings INC | 股票-医疗保健 | 2.02% | -0.11% | -40.60% | |
| 25 | INSM | Insmed INC | 股票-医疗保健 | 1.92% | +0.37% | +249.58% | |
| 26 | NAMS | NewAmsterdam Pharma Company N.V. | 股票-其他 | 1.78% | -0.43% | -51.89% | |
| 27 | CELC | Celcuity INC | 股票-其他 | 1.66% | +0.33% | +237.78% | |
| 28 | ABVX | Abivax Sa-adr | 股票-其他 | 1.54% | +0.18% | — | |
| 29 | CAH | Cardinal Health INC | 股票-医疗保健 | 1.54% | — | +363.07% | |
| 30 | IDYA | Ideaya Biosciences INC | 股票-其他 | 1.30% | +0.23% | -68.05% | |
| 31 | TNGX | Tango Therapeutics INC | 股票-其他 | 1.17% | +1.17% | NEW | |
| 32 | SYRE | Spyre Therapeutics INC | 股票-其他 | 1.13% | +1.13% | NEW | |
| 33 | IRON | Disc Medicine INC | 股票-其他 | 1.03% | -0.19% | +123.60% | |
| 34 | CMPX | Compass Therapeutics INC | 股票-其他 | 0.99% | -0.01% | -92.84% | |
| 35 | UNH | Unitedhealth Group INC | 股票-医疗保健 | 0.90% | -0.12% | — | |
| 36 | DXCM | Dexcom INC | 股票-医疗保健 | 0.85% | +0.01% | +1371.05% | |
| 37 | BCAX | Bicara Therapeutics INC | 股票-其他 | 0.75% | +0.15% | +950.29% | |
| 38 | SLNOEUR | Soleno Therapeutics INC | 股票-其他 | 0.71% | -0.22% | +43.75% | |
| 39 | PYXS | Pyxis Oncology INC | 股票-其他 | 0.52% | +0.29% | -68.08% |
Q3 2026表现
+14.9%
近4个季度表现
+32%
基于可获取价格的持仓（占申报价值的55%）计算
| 季度 | 持股只数 | 总市值 | 稳定性 | 主要持股 |
|---|---|---|---|---|
| 2026-03-31 | 39 | US$3.1亿 | 32 | |
| 2025-12-31 | 39 | US$3.1亿 | 100 | |
| 2025-09-30 | 38 | US$2696.9万 | 100 | |
| 2025-06-30 | 37 | US$2.3亿 | 0 | |
| 2025-03-31 | 37 | US$2.3亿 | 100 | |
| 2024-12-31 | 36 | US$2.1亿 | 0 | |
| 2024-09-30 | 36 | US$2.1亿 | 0 | |
| 2024-06-30 | 38 | US$1.6亿 | 0 | |
| 2024-03-31 | 44 | US$1.6亿 | 0 | |
| 2023-12-31 | 45 | US$1.3亿 | 0 | |
| 2022-12-31 | 53 | US$5178.6万 | 0 | |
| 2022-09-30 | 10 | US$4734.2万 | 0 | |
| 2022-06-30 | 12 | US$4338.0万 | 0 | |
| 2022-03-31 | 12 | US$6280.6万 | 0 | |
| 2021-12-31 | 13 | US$7096.6万 | 0 | |
| 2021-09-30 | 17 | US$6676.3万 | 0 | |
| 2021-06-30 | 9 | US$1.1亿 | 100 | |
| 2021-03-31 | 15 | US$1.3亿 | 69 | |
| 2020-12-31 | 17 | US$1.5亿 | 100 | |
| 2017-12-31 | 16 | US$4738.5万 | 90 | |
| 2017-09-30 | 12 | US$8564.2万 | 42 | |
| 2017-06-30 | 11 | US$8019.6万 | 93 | |
| 2017-03-31 | 10 | US$6521.3万 | 100 | |
| 2016-12-31 | 15 | US$1.1亿 | 67 | |
| 2016-09-30 | 15 | US$1.3亿 | 68 | |
| 2016-06-30 | 18 | US$2.2亿 | 42 | |
| 2016-03-31 | 18 | US$2.1亿 | 70 | |
| 2015-12-31 | 14 | US$2.1亿 | 63 | |
| 2015-09-30 | 14 | US$1.7亿 | 55 | |
| 2015-06-30 | 14 | US$2.0亿 | 48 | |
| 2015-03-31 | 15 | US$1.4亿 | 39 | |
| 2014-12-31 | 16 | US$1.2亿 | 81 | |
| 2014-09-30 | 16 | US$1.4亿 | 34 | |
| 2014-06-30 | 19 | US$1.8亿 | 32 | |
| 2014-03-31 | 18 | US$1.4亿 | 71 | |
| 2013-12-31 | 18 | US$1.0亿 | — |
Atle Fund Management AB 在 2026-03-31 最显著的持仓异动： 新建仓: Johnson & Johnson (JNJ); 新建仓: Edwards Lifesciences CORP (EW); 清仓: Ufp Technologies INC (UFPT); 新建仓: Tango Therapeutics INC (TNGX); 新建仓: Spyre Therapeutics INC (SYRE).
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | MRK | Merck & Co. INC. | +0.8% | -82.71% | 减仓 |
| 2 | MIRM | Mirum Pharmaceuticals INC | +0.8% | +118.28% | 加仓 |
| 3 | IONS | Ionis Pharmaceuticals INC | +0.7% | -69.83% | 减仓 |
| 4 | RVMD | Revolution Medicines INC | +0.6% | +584.43% | 加仓 |
| 5 | AMGN | Amgen INC | +0.5% | — | 不变 |
| 6 | ALKS | Alkermes plc | +0.5% | — | 不变 |
| 7 | BBIO | Bridgebio Pharma INC | +0.4% | -21.18% | 减仓 |
| 8 | INSM | Insmed INC | +0.4% | +249.58% | 加仓 |
| 9 | INCY | Incyte CORP | +0.3% | -28.31% | 减仓 |
| 10 | CELC | Celcuity INC | +0.3% | +237.78% | 加仓 |
| 11 | GILD | Gilead Sciences INC | +0.3% | -5.57% | 减仓 |
| 12 | PYXS | Pyxis Oncology INC | +0.3% | -68.08% | 减仓 |
| 13 | CVS | Cvs Health CORP | +0.3% | -77.68% | 减仓 |
| 14 | VRTX | Vertex Pharmaceuticals INC | +0.3% | — | 不变 |
| 15 | IDYA | Ideaya Biosciences INC | +0.2% | -68.05% | 减仓 |
| 16 | ABVX | Abivax Sa-adr | +0.2% | — | 不变 |
| 17 | BCAX | Bicara Therapeutics INC | +0.2% | +950.29% | 加仓 |
| 18 | SYK | Stryker CORP | +0.1% | — | 不变 |
| 19 | DXCM | Dexcom INC | 0% | +1371.05% | 加仓 |
| 20 | ONC | Beone Medicines Ltd-adr | — | +3.18% | 加仓 |
| 21 | CAH | Cardinal Health INC | — | +363.07% | 加仓 |
| 22 | CMPX | Compass Therapeutics INC | 0% | -92.84% | 减仓 |
| 23 | IRTC | Irhythm Holdings INC | -0.1% | -40.60% | 减仓 |
| 24 | UNH | Unitedhealth Group INC | -0.1% | — | 不变 |
| 25 | IRON | Disc Medicine INC | -0.2% | +123.60% | 加仓 |
| 26 | SLNOEUR | Soleno Therapeutics INC | -0.2% | +43.75% | 加仓 |
| 27 | COR | Cencora INC | -0.4% | -1.27% | 减仓 |
| 28 | NAMS | NewAmsterdam Pharma Company N.V. | -0.4% | -51.89% | 减仓 |
| 29 | BSX | Boston Scientific CORP | -0.5% | -62.80% | 减仓 |
| 30 | KRYS | Krystal Biotech INC | -0.5% | +11.01% | 加仓 |
| 31 | TMO | Thermo Fisher Scientific INC | -0.9% | -23.16% | 减仓 |
| 32 | ISRG | Intuitive Surgical INC | -1% | +217.40% | 加仓 |
| 33 | NBIX | Neurocrine Biosciences INC | -1.8% | -5.39% | 减仓 |
| 34 | LLY | Eli Lilly & Co | -2% | +27.59% | 加仓 |
| 35 | ABBV | Abbvie INC | -4.5% | — | 不变 |
| 36 | JNJ | Johnson & Johnson | — | NEW | 新建仓 |
| 37 | EW | Edwards Lifesciences CORP | — | NEW | 新建仓 |
| 38 | UFPT | Ufp Technologies INC | — | EXIT | 清仓 |
| 39 | TNGX | Tango Therapeutics INC | — | NEW | 新建仓 |
| 40 | SYRE | Spyre Therapeutics INC | — | NEW | 新建仓 |
| 41 | ACLXGBX | Arcellx INC | — | EXIT | 清仓 |
| 42 | AUTL | Autolus Therapeutics PLC | — | EXIT | 清仓 |
| 43 | CRBP | Corbus Pharmaceuticals Holdi | — | EXIT | 清仓 |
| 季度 | 申报日期 | 类型 | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-11 | 13F-HR | 在 EDGAR 上查看 |
| 2025-12-31 | 2026-02-06 | 13F-HR | 在 EDGAR 上查看 |
| 2025-09-30 | 2025-11-04 | 13F-HR | 在 EDGAR 上查看 |
| 2025-06-30 | 2025-07-14 | 13F-HR | 在 EDGAR 上查看 |
| 2025-03-31 | 2025-05-05 | 13F-HR | 在 EDGAR 上查看 |
| 2024-12-31 | 2025-02-04 | 13F-HR | 在 EDGAR 上查看 |
| 2024-09-30 | 2024-11-12 | 13F-HR | 在 EDGAR 上查看 |
| 2024-06-30 | 2024-08-14 | 13F-HR | 在 EDGAR 上查看 |
| 2024-03-31 | 2024-04-25 | 13F-HR | 在 EDGAR 上查看 |
| 2023-12-31 | 2024-01-30 | 13F-HR | 在 EDGAR 上查看 |
| 2022-12-31 | 2023-02-14 | 13F-HR | 在 EDGAR 上查看 |
| 2022-09-30 | 2022-10-21 | 13F-HR | 在 EDGAR 上查看 |
| 2022-06-30 | 2022-07-08 | 13F-HR | 在 EDGAR 上查看 |
| 2022-03-31 | 2022-05-05 | 13F-HR | 在 EDGAR 上查看 |
| 2021-12-31 | 2022-01-18 | 13F-HR | 在 EDGAR 上查看 |
| 2021-09-30 | 2021-11-08 | 13F-HR | 在 EDGAR 上查看 |
| 2021-06-30 | 2021-08-10 | 13F-HR | 在 EDGAR 上查看 |
| 2021-03-31 | 2021-04-30 | 13F-HR | 在 EDGAR 上查看 |
| 2020-12-31 | 2021-02-05 | 13F-HR | 在 EDGAR 上查看 |
| 2017-12-31 | 2018-02-09 | 13F-HR | 在 EDGAR 上查看 |
| 2017-09-30 | 2017-11-13 | 13F-HR | 在 EDGAR 上查看 |
| 2017-06-30 | 2017-08-07 | 13F-HR | 在 EDGAR 上查看 |
| 2017-03-31 | 2017-04-28 | 13F-HR | 在 EDGAR 上查看 |
| 2016-12-31 | 2017-01-24 | 13F-HR | 在 EDGAR 上查看 |
| 2016-09-30 | 2016-10-24 | 13F-HR | 在 EDGAR 上查看 |
| 2016-06-30 | 2016-07-26 | 13F-HR | 在 EDGAR 上查看 |
| 2016-03-31 | 2016-04-19 | 13F-HR | 在 EDGAR 上查看 |
| 2015-12-31 | 2016-01-11 | 13F-HR | 在 EDGAR 上查看 |
| 2015-09-30 | 2015-10-13 | 13F-HR | 在 EDGAR 上查看 |
| 2015-06-30 | 2015-07-20 | 13F-HR | 在 EDGAR 上查看 |
| 2015-03-31 | 2015-04-20 | 13F-HR | 在 EDGAR 上查看 |
| 2014-12-31 | 2015-01-21 | 13F-HR | 在 EDGAR 上查看 |
| 2014-09-30 | 2014-10-14 | 13F-HR | 在 EDGAR 上查看 |
| 2014-06-30 | 2014-07-17 | 13F-HR | 在 EDGAR 上查看 |
| 2014-03-31 | 2014-04-23 | 13F-HR | 在 EDGAR 上查看 |
| 2013-12-31 | 2014-02-05 | 13F-HR | 在 EDGAR 上查看 |
资产规模相近的机构
CIK 0001666613
申报总市值
US$3.1亿
74 stks
2026-03-31
资产规模与本机构相差仅 0.0%
CIK 0001633625
申报总市值
US$3.1亿
67 stks
2026-03-31
资产规模与本机构相差仅 0.0%
CIK 0001691170
申报总市值
US$3.1亿
22 stks
2026-03-31
资产规模与本机构相差仅 0.0%
持仓风格相似的机构
CIK 0001387980
申报总市值
US$1.1亿
117 stks
2015-09-30
数据过旧，未更新
前五大持仓重叠 3/5 档，同样重仓 Eli Lilly & Co
CIK 0000315032
申报总市值
US$1268.6亿
197 stks
2026-03-31
前五大持仓重叠 2/5 档，同样重仓 Eli Lilly & Co
CIK 0000872259
申报总市值
US$198.3亿
327 stks
2026-03-31
前五大持仓重叠 2/5 档，同样重仓 Johnson & Johnson